Vascular Endothelial Growth Factor (VEGF) Ligand and Receptor Induction in Rat Renal Allograft Rejection

Transplantation Proceedings

Volumn 38, Issue 10, 2006, Pages 3236-3238

  Rintala, S E ^a   Savikko, J ^a,b   Rintala, J M ^a   von Willebrand, E ^a  

^a HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^b PÄIJÄT HÄME CENTRAL HOSPITAL   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN A; IMMUNOSUPPRESSIVE AGENT; LIGAND; VASCULOTROPIN; VASCULOTROPIN RECEPTOR 1;

ACUTE GRAFT REJECTION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHRONIC ALLOGRAFT NEPHROPATHY; CHRONIC GRAFT REJECTION; CONTROLLED STUDY; DIABETIC NEPHROPATHY; DRUG MECHANISM; ENDOTHELIUM; GRAFT REJECTION; HISTOLOGY; IMMUNOHISTOCHEMISTRY; KIDNEY ALLOGRAFT REJECTION; KIDNEY TRANSPLANTATION; NONHUMAN; PREECLAMPSIA; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; RAT; RISK FACTOR;

ACUTE DISEASE; ANIMALS; GRAFT REJECTION; IMMUNOHISTOCHEMISTRY; KIDNEY TRANSPLANTATION; LIGANDS; RATS; RATS, INBRED STRAINS; RATS, INBRED WF; TRANSPLANTATION, HOMOLOGOUS; TRANSPLANTATION, ISOGENEIC; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-1;

EID: 33845381590     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transproceed.2006.10.049     Document Type: Article

References (9)

1. Honkanen E., von Willebrand E., Koskinen P., et al. Decreased expression of vascular endothelial growth factor in idiopathic membranous glomerulonephritis: relationships to clinical course. Am J Kidney Dis 42 (2003) 1139
2. Villegas G., Lange-Sperandio B., and Tufro A. Autocrine and paracrine functions of vascular endothelial growth factor (VEGF) in renal tubular epithelial cells. Kidney Int 67 (2005) 449
3. Lemstrom K.B., Nykanen A.I., Tikkanen J.M., et al. Role of angiogenic growth factors in transplant coronary artery disease. Ann Med 36 (2004) 184 (Review)
4. Nakagawa T., Sato W., Sautin Y.Y., et al. Uncoupling of vascular endothelial growth factor with nitric oxide as a mechanism for diabetic vasculopathy. J Am Soc Nephrol 17 (2006) 736 (Epub 2006 Jan 25)
5. Schrijvers B.F., Flyvbjerg A., and De Vriese A.S. The role of vascular endothelial growth factor (VEGF) in renal pathophysiology. Kidney Int 65 (2004) 2003 (Review)
6. De Vriese A.S., Tilton R.G., Elger M., et al. Antibodies against vascular endothelial growth factor improve early renal dysfunction in experimental diabetes. J Am Soc Nephrol 12 (2001) 993
7. Pilmore H.L., Eris J.M., Painter D.M., et al. Vascular endothelial growth factor expression in human chronic renal allograft rejection. Transplantation 67 (1999) 929
8. Gröne H.J., Simon M., and Gröne E.F. Expression of vascular endothelial growth factor in renal vascular disease and renal allografts. J Pathol 177 (1995) 259
9. Ozdemir B.H., Ozdemir F.N., Haberal N., et al. Vascular endothelial growth factor expression and cyclosporine toxicity in renal allograft rejection. Am J Transplant 5 4 Pt 1 (2005) 766